Catherine Jennings - Boston Scientific VP Interventions
| BSX Stock | EUR 85.50 1.50 1.72% |
Insider
Catherine Jennings is VP Interventions of Boston Scientific
| Phone | 508 683 4000 |
| Web | https://www.bostonscientific.com |
Boston Scientific Management Efficiency
The company has return on total asset (ROA) of 0.0393 % which means that it generated a profit of $0.0393 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0408 %, meaning that it generated $0.0408 on every $100 dollars invested by stockholders. Boston Scientific's management efficiency ratios could be used to measure how well Boston Scientific manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Dirksen Lehman | Edwards Lifesciences | N/A | |
| Andrew Pierce | Stryker | 49 | |
| Denise Fleming | Becton Dickinson and | N/A | |
| Troy Kirkpatrick | Becton Dickinson and | N/A | |
| Larry Wood | Edwards Lifesciences | 57 | |
| Scott Ullem | Edwards Lifesciences | 56 | |
| Jennifer Kirk | Medtronic PLC | 48 | |
| Scott Leinenweber | Abbott Laboratories | 51 | |
| Mark Wilterding | Edwards Lifesciences | N/A | |
| Robert Funck | Abbott Laboratories | 62 | |
| JeanLuc Lemercier | Edwards Lifesciences | 66 | |
| Mary Moreland | Abbott Laboratories | 57 | |
| Hubert Allen | Abbott Laboratories | 57 | |
| Christopher DelOrefice | Becton Dickinson and | 52 | |
| MSc MD | Medtronic PLC | N/A | |
| Mark Ploof | Medtronic PLC | N/A | |
| Arnold Pinkston | Edwards Lifesciences | 64 | |
| Donald Bobo | Edwards Lifesciences | 61 | |
| Thomas Spoerel | Becton Dickinson and | 45 | |
| Elaine Leavenworth | Abbott Laboratories | 64 | |
| Robert Ford | Abbott Laboratories | 49 | |
Management Performance
| Return On Equity | 0.0408 | |||
| Return On Asset | 0.0393 |
Boston Scientific Leadership Team
Elected by the shareholders, the Boston Scientific's board of directors comprises two types of representatives: Boston Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Boston. The board's role is to monitor Boston Scientific's management team and ensure that shareholders' interests are well served. Boston Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Boston Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jodi Eddy, VP Officer | ||
| Vance Brown, Gen VP | ||
| Catherine Jennings, VP Interventions | ||
| Joseph Fitzgerald, Ex Cardiology | ||
| John Sorenson, Ex Operations | ||
| Daniel Brennan, Ex CFO | ||
| Jeffrey Mirviss, Ex Interventions | ||
| Michael Mahoney, Pres Chairman | ||
| Jonathan Monson, Global VP | ||
| Susan Lisa, VP Relations |
Boston Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Boston Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0408 | |||
| Return On Asset | 0.0393 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 72.27 B | |||
| Shares Outstanding | 1.43 B | |||
| Shares Owned By Insiders | 0.20 % | |||
| Shares Owned By Institutions | 94.00 % | |||
| Price To Earning | 317.20 X | |||
| Price To Book | 3.80 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Boston Stock
Boston Scientific financial ratios help investors to determine whether Boston Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boston with respect to the benefits of owning Boston Scientific security.